Adamas Pharmaceuticals Inc·4

May 6, 5:04 PM ET

Adamas Pharmaceuticals Inc 4

4 · Adamas Pharmaceuticals Inc · Filed May 6, 2015

Insider Transaction Report

Form 4
Period: 2015-05-04
Transactions
  • Sale

    Common Stock

    2015-05-04$16.82/sh3,000$50,46069,000 total
Holdings
  • Common Stock

    (indirect: Ivan Lieberburg and Janice Kirsch as CPWTROS)
    16,000
Footnotes (1)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24.4_580164

    POA DOCUMENT